Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome—LIPGENE: a European randomized dietary intervention study

被引：0

作者：

A C Tierney

J McMonagle

D I Shaw

H L Gulseth

O Helal

W H M Saris

J A Paniagua

I Gołąbek-Leszczyñska

C Defoort

C M Williams

B Karsltröm

B Vessby

A Dembinska-Kiec

J López-Miranda

E E Blaak

C A Drevon

M J Gibney

J A Lovegrove

H M Roche

机构：

[1] Nutrigenomics Research Group,Department of Endocrinology

[2] UCD Conway Institute & UCD Institute of Food & Health,Department of Nutrition

[3] University College Dublin,Department of Human Biology

[4] Hugh Sinclair Unit of Human Nutrition & Institute for Cardiovascular and Metabolic Research,Department of Clinical Biochemistry

[5] University of Reading,Department of Public Health and Caring Sciences/Clinical Nutrition and Metabolism

[6] Oslo University Hospital Aker,undefined

[7] Institute of Basic Medical Sciences,undefined

[8] Faculty of Medicine,undefined

[9] University of Oslo,undefined

[10] INSERM,undefined

[11] 476 Human Nutrition and Lipids,undefined

[12] INRA,undefined

[13] 1260,undefined

[14] University Méditerranée Aix-Marseille 2,undefined

[15] Faculty of Medicine,undefined

[16] IPHM-IFR 125,undefined

[17] Nutrition and Toxicology Research Institute Maastricht,undefined

[18] Lipid and Atherosclerosis Unit,undefined

[19] Reina Sofia University Hospital,undefined

[20] School of Medicine,undefined

[21] University of Cordoba,undefined

[22] CIBER Physiopathology of Obesity and Nutrition,undefined

[23] Jagiellonian University Medical College,undefined

[24] Kopernika 15A,undefined

[25] Uppsala University,undefined

来源：

International Journal of Obesity | 2011年 / 35卷

关键词：

dietary fat; insulin sensitivity; SFA; LC n-3 PUFA; MetS; LIPGENE;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：800 / 809

页数：9

共 176 条

[1] Carr DB(2004)Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome Diabetes 53 2087-2094
[2] Utzschneider KM(2001)Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 683-689
[3] Hull RL(2005)Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2735-2752
[4] Kodama K(2005)Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence Diabetes Care 28 1769-1778
[5] Retzlaff BM(2005)Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus Circulation 112 3066-3072
[6] Brunzell JD(2008)Insulin sensitivity: modulation by nutrients and inflammation J Clin Invest 118 2992-3002
[7] Isomaa B(2002)Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 3143-3421
[8] Almgren P(2005)The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial Ann Intern Med 142 611-619
[9] Tuomi T(2003)Lifestyle intervention according to general recommendations improves glucose tolerance Obes Res 11 1588-1596
[10] Forsen B(2002)Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N Engl J Med 346 393-403

← 1 2 3 4 5 6 7 8 9 10 →